News Daily News CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions Caitlin E. Cox September 20, 2019
News Industry News Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board September 20, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Daily News Higher Mortality With Off-Pump CABG: EXCEL Analysis Michael O'Riordan August 08, 2019
News Daily News Stroke After PCI: Rare but Rising as Patient Complexity Climbs Todd Neale August 05, 2019
News Daily News Best Strategy Questioned for NSTE ACS Patients With Prior CABG Shelley Wood August 05, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: The Push for High-Sensitivity Troponin August 02, 2019
Presentation CHIP Seattle 2019 All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support Presenter: William W. O’Neill August 02, 2019
Presentation CHIP Seattle 2019 Complex Coronary Intervention Programs Dedication for Advancement Presenter: David E. Kandzari August 02, 2019
News Daily News Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery Michael O'Riordan July 29, 2019
News Industry News SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz July 11, 2019
News Daily News Upswing Seen in US Adult and Pediatric In-Hospital Cardiac Arrests Marcus A. Banks July 10, 2019
News Daily News Hybrid Revascularization for Multivessel CAD Rarely Used in the US Todd Neale July 04, 2019
News Opinion Fellow Talk Hemodynamics: The Forgotten Branch of Cardiology Mesfer Alfadhel, MD June 28, 2019
News Daily News CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors Caitlin E. Cox June 12, 2019
News Industry News Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories June 07, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019